• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大脑健康平台:结合韧性、脆弱性和表现来评估大脑健康以及阿尔茨海默病和相关疾病的风险。

The Brain Health Platform: Combining Resilience, Vulnerability, and Performance to Assess Brain Health and Risk of Alzheimer's Disease and Related Disorders.

机构信息

Comprehensive Center for Brain Health, Department of Neurology, University of Miami Miller School of Medicine, Boca Raton, FL, USA.

Department of Mathematical Sciences, Florida Atlantic University, Boca Raton, FL, USA.

出版信息

J Alzheimers Dis. 2022;90(4):1817-1830. doi: 10.3233/JAD-220927.

DOI:10.3233/JAD-220927
PMID:36336936
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10515193/
Abstract

BACKGROUND

It is difficult to assess brain health status and risk of cognitive impairment, particularly at the initial evaluation. To address this, we developed the Brain Health Platform to quantify brain health and identify Alzheimer's disease and related disorders (ADRD) risk factors by combining a measure of brain health: the Resilience Index (RI), a measure of risk of ADRD; the Vulnerability Index (VI); and the Number-Symbol Coding Task (NSCT), a measure of brain performance.

OBJECTIVE

The Brain Health Platform is intended to be easily and quickly administered, providing an overview of a patient's risk of developing future impairment based on modifiable and non-modifiable factors as well as current cognitive performance.

METHODS

This cross-sectional study comprehensively evaluated 230 participants (71 controls, 71 mild cognitive impairment, 88 ADRD). VI and RI scores were derived from physical assessments, lifestyle questionnaires, demographics, medical history, and neuropsychological examination including the NSCT.

RESULTS

Individuals with abnormal scores were 95.7% likely to be impaired, with a misclassification rate of 9.7%. The combined model had excellent discrimination (AUC:0.923±0.053; p < 0.001), performing better than the Montreal Cognitive Assessment.

CONCLUSION

The Brain Health Platform combines measures of resilience, vulnerability, and performance to provide a cross-sectional snapshot of overall brain health. The Brain Health Platform can effectively and accurately identify even the very mildest impairments due to ADRD, leveraging brief yet powerful and actionable indices of brain health and risk that could be used to develop personalized, precision medicine-like interventions.

摘要

背景

评估大脑健康状况和认知障碍风险,尤其是在初始评估时,具有一定难度。为解决这一问题,我们开发了大脑健康平台,通过整合大脑健康测量指标、阿尔茨海默病和相关疾病(ADRD)风险测量指标,来量化大脑健康并识别 ADRD 风险因素。该测量指标包括:大脑健康测量指标-韧性指数(RI)、ADRD 风险测量指标-脆弱性指数(VI)、大脑性能测量指标-数字符号编码测试(NSCT)。

目的

大脑健康平台旨在便于快速管理,基于可改变和不可改变因素以及当前认知表现,为患者提供未来发生损害的风险概况。

方法

本横断面研究全面评估了 230 名参与者(71 名对照者、71 名轻度认知障碍者、88 名 ADRD 患者)。VI 和 RI 评分来自体格检查、生活方式问卷、人口统计学、病史和神经心理学检查,包括 NSCT。

结果

异常分数的个体有 95.7%的可能受损,错误分类率为 9.7%。综合模型具有出色的辨别力(AUC:0.923±0.053;p<0.001),优于蒙特利尔认知评估。

结论

大脑健康平台整合了韧性、脆弱性和表现测量指标,提供了大脑健康的整体横断面图像。大脑健康平台可以有效地、准确地识别出 ADRD 导致的最轻微的损害,它利用了简短而强大且可操作的大脑健康和风险指标,可以用于制定个性化、精准医学干预措施。

相似文献

1
The Brain Health Platform: Combining Resilience, Vulnerability, and Performance to Assess Brain Health and Risk of Alzheimer's Disease and Related Disorders.大脑健康平台:结合韧性、脆弱性和表现来评估大脑健康以及阿尔茨海默病和相关疾病的风险。
J Alzheimers Dis. 2022;90(4):1817-1830. doi: 10.3233/JAD-220927.
2
The Resilience Index: A Quantifiable Measure of Brain Health and Risk of Cognitive Impairment and Dementia.韧性指数:大脑健康和认知障碍及痴呆风险的可量化指标。
J Alzheimers Dis. 2021;84(4):1729-1746. doi: 10.3233/JAD-215077.
3
The Number Symbol Coding Task: A brief measure of executive function to detect dementia and cognitive impairment.数字符号编码任务:一种用于检测痴呆和认知障碍的简短执行功能测量工具。
PLoS One. 2020 Nov 30;15(11):e0242233. doi: 10.1371/journal.pone.0242233. eCollection 2020.
4
Using Optical Coherence Tomography to Screen for Cognitive Impairment and Dementia.使用光学相干断层扫描筛查认知障碍和痴呆。
J Alzheimers Dis. 2021;84(2):723-736. doi: 10.3233/JAD-210328.
5
Social Determinants of Health, Risk and Resilience against Alzheimer's Disease and Related Dementias: The Healthy Brain Initiative.健康的社会决定因素、抵御阿尔茨海默病及相关痴呆症的风险与恢复力:健康大脑倡议
J Alzheimers Dis Rep. 2024 Apr 8;8(1):637-646. doi: 10.3233/ADR-230155. eCollection 2024.
6
Exploring Reasons for Differential Vulnerability and Alzheimer's Disease Risk in Racial and Ethnic Minorities.探讨少数族裔在易感性和阿尔茨海默病风险方面存在差异的原因。
J Alzheimers Dis. 2023;91(1):495-506. doi: 10.3233/JAD-220959.
7
Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.剑桥认知功能检查表第三版:对轻度认知功能障碍和痴呆的诊断效用以及与标准化神经心理学测试的相关性
Int Psychogeriatr. 2017 Jan;29(1):105-113. doi: 10.1017/S1041610216001496. Epub 2016 Sep 29.
8
[Awareness disorders in Alzheimer's disease and in mild cognitive impairment].[阿尔茨海默病和轻度认知障碍中的意识障碍]
Encephale. 2014 Apr;40(2):180-7. doi: 10.1016/j.encep.2013.10.003. Epub 2014 Mar 11.
9
10
Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological study.帕金森病认知障碍的多因素性:一项神经心理学研究。
Acta Neurol Scand. 2020 Jun;141(6):500-508. doi: 10.1111/ane.13226. Epub 2020 Feb 27.

引用本文的文献

1
The Healthy Brain 9 (HB9): A new instrument to characterize subjective cognitive decline, and detect anosognosia in mild cognitive impairment.健康大脑9(HB9):一种用于表征主观认知衰退并检测轻度认知障碍中疾病感缺失的新工具。
PLoS One. 2025 Jun 24;20(6):e0322351. doi: 10.1371/journal.pone.0322351. eCollection 2025.
2
Empagliflozin and memantine combination ameliorates cognitive impairment in scopolamine + heavy metal mixture-induced Alzheimer's disease in rats: role of AMPK/mTOR, BDNF, BACE-1, neuroinflammation, and oxidative stress.恩格列净与美金刚联合用药改善东莨菪碱+重金属混合物诱导的大鼠阿尔茨海默病认知障碍:AMPK/mTOR、BDNF、BACE-1、神经炎症和氧化应激的作用
Inflammopharmacology. 2025 May 5. doi: 10.1007/s10787-025-01755-5.
3
The Healthy Brain 9 (HB9): A New Instrument to Characterize Subjective Cognitive Decline, and Detect Anosognosia in Mild Cognitive Impairment.健康大脑9(HB9):一种用于表征主观认知衰退并检测轻度认知障碍中疾病感缺失的新工具。
medRxiv. 2025 Mar 23:2025.03.23.25324480. doi: 10.1101/2025.03.23.25324480.
4
Improving Early Detection of Cognitive Impairment in Older Adults in Primary Care Clinics: Recommendations From an Interdisciplinary Geriatrics Summit.提高初级保健诊所中老年认知障碍的早期检测:跨学科老年医学峰会的建议。
Ann Fam Med. 2024 Nov-Dec;22(6):543-549. doi: 10.1370/afm.3174.
5
Social Determinants of Health, Risk and Resilience against Alzheimer's Disease and Related Dementias: The Healthy Brain Initiative.健康的社会决定因素、抵御阿尔茨海默病及相关痴呆症的风险与恢复力:健康大脑倡议
J Alzheimers Dis Rep. 2024 Apr 8;8(1):637-646. doi: 10.3233/ADR-230155. eCollection 2024.
6
The Mediating Role of Cortical Atrophy on the Relationship between the Resilience Index and Cognitive Function: Findings from the Healthy Brain Initiative.皮质萎缩对韧性指数与认知功能关系的中介作用:来自健康大脑倡议的研究结果。
J Alzheimers Dis. 2024;98(3):1017-1027. doi: 10.3233/JAD-231346.
7
What is brain health?什么是大脑健康?
Cereb Circ Cogn Behav. 2023 Oct 25;6:100190. doi: 10.1016/j.cccb.2023.100190. eCollection 2024.
8
The Healthy Brain Initiative (HBI): A prospective cohort study protocol.健康大脑倡议(HBI):一项前瞻性队列研究方案。
PLoS One. 2023 Oct 27;18(10):e0293634. doi: 10.1371/journal.pone.0293634. eCollection 2023.

本文引用的文献

1
Cognitive Resilience in Brain Health and Dementia Research.脑健康与痴呆研究中的认知弹性。
J Alzheimers Dis. 2022;90(2):461-473. doi: 10.3233/JAD-220755.
2
Amyloid-PET Levels in the Precuneus and Posterior Cingulate Cortices Are Associated with Executive Function Scores in Preclinical Alzheimer's Disease Prior to Overt Global Amyloid Positivity.淀粉样蛋白-PET 在前扣带回和后扣带回皮质中的水平与临床前阿尔茨海默病在出现明显全局淀粉样蛋白阳性之前的执行功能评分相关。
J Alzheimers Dis. 2022;88(3):1127-1135. doi: 10.3233/JAD-220294.
3
2022 Alzheimer's disease facts and figures.2022 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2022 Apr;18(4):700-789. doi: 10.1002/alz.12638. Epub 2022 Mar 14.
4
The Vulnerability Index: A weighted measure of dementia and cognitive impairment risk.脆弱性指数:痴呆症和认知障碍风险的加权衡量指标。
Alzheimers Dement (Amst). 2021 Dec 9;13(1):e12249. doi: 10.1002/dad2.12249. eCollection 2021.
5
The Resilience Index: A Quantifiable Measure of Brain Health and Risk of Cognitive Impairment and Dementia.韧性指数:大脑健康和认知障碍及痴呆风险的可量化指标。
J Alzheimers Dis. 2021;84(4):1729-1746. doi: 10.3233/JAD-215077.
6
Medical and Social Determinants of Brain Health and Dementia in a Multicultural Community Cohort of Older Adults.医学和社会因素对多元文化老年人群大脑健康和痴呆的影响:一项队列研究。
J Alzheimers Dis. 2021;84(4):1563-1576. doi: 10.3233/JAD-215020.
7
Plasma p-tau181 Level Predicts Neurodegeneration and Progression to Alzheimer's Dementia: A Longitudinal Study.血浆p-tau181水平可预测神经退行性变及向阿尔茨海默病痴呆的进展:一项纵向研究。
Front Neurol. 2021 Sep 7;12:695696. doi: 10.3389/fneur.2021.695696. eCollection 2021.
8
Blood pressure, executive function, and network connectivity in middle-aged adults at risk of dementia in late life.中老年人群中处于晚年痴呆风险的血压、执行功能和网络连通性。
Proc Natl Acad Sci U S A. 2021 Sep 14;118(37). doi: 10.1073/pnas.2024265118.
9
A Modified CAIDE Risk Score as a Screening Tool for Cognitive Impairment in Older Adults.改良的 CAIDE 风险评分作为老年人认知障碍的筛查工具。
J Alzheimers Dis. 2021;82(4):1755-1768. doi: 10.3233/JAD-210269.
10
Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021.早期阿尔茨海默病的诊断:2021 年的临床实践。
J Prev Alzheimers Dis. 2021;8(3):371-386. doi: 10.14283/jpad.2021.23.